协商公平获得流感疫苗的机会：全球卫生外交以及禽流感 H5N1 和大流行性流感 H1N1 引发的争议。
Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1.
机构信息
Maurer School of Law, Indiana University, Bloomington, Indiana, United States of America.
出版信息
PLoS Med. 2010 May 4;7(5):e1000247. doi: 10.1371/journal.pmed.1000247.
Abstract
As part of the series on Global Health Diplomacy, David Fidler provides a case study of the difficult negotiations to increase equitable access to vaccines for highly pathogenic avian influenza A (H5N1) and pandemic 2009 influenza A (H1N1).
摘要
作为全球卫生外交系列的一部分，大卫·菲德勒提供了一个关于增加高致病性禽流感 A（H5N1）和大流行性流感 A（H1N1）疫苗公平获取的艰难谈判的案例研究。
相似文献
1
Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1.协商公平获得流感疫苗的机会：全球卫生外交以及禽流感 H5N1 和大流行性流感 H1N1 引发的争议。
PLoS Med. 2010 May 4;7(5):e1000247. doi: 10.1371/journal.pmed.1000247.
2
Avian influenza aided readiness for swine flu.禽流感有助于为应对猪流感做好准备。
Nature. 2009 Jun 11;459(7248):756-7. doi: 10.1038/459756a.
3
Overview of avian and pandemic influenza--preparedness and response.禽流感应急与大流行性流感概述——防范与应对
J Indian Med Assoc. 2009 Aug;107(8):511-2, 519.
4
H5N1 avian influenza: first steps towards development of a human vaccine.H5N1型禽流感：人类疫苗研发的初步进展
Wkly Epidemiol Rec. 2005 Aug 19;80(33):277-8.
5
Epidemiology of seasonal, avian and pandemic influenza.季节性、禽流感和大流行性流感的流行病学
J Indian Med Assoc. 2009 Aug;107(8):506-7.
6
[Preparedness and international contribution on H5N1 highly pathogenic avian influenza and pandemic-influenza].关于H5N1高致病性禽流感和大流行性流感的防范与国际贡献
Uirusu. 2006 Jun;56(1):77-84. doi: 10.2222/jsv.56.77.
7
Avian influenza and the failure of public rationing discussions.禽流感与公共配给讨论的失败。
J Law Med Ethics. 2006 Fall;34(3):620-3. doi: 10.1111/j.1748-720x.2006.00076.x.
8
Strategic analysis on responding human avian flu and flu pandemic in China.中国应对人感染禽流感及流感大流行的策略分析
Biomed Environ Sci. 2006 Apr;19(2):158-61.
9
Vaccines for a potential influenza pandemic.针对潜在流感大流行的疫苗。
Future Microbiol. 2007 Jun;2(3):345-9. doi: 10.2217/17460913.2.3.345.
10
Pandemic H5N1 influenza.甲型H5N1流感大流行
J Trop Pediatr. 2007 Apr;53(2):73-5. doi: 10.1093/tropej/fmm013.
引用本文的文献
1
COVAX and COVID-19 Vaccine Inequity: A case study of G-20 and African Union.新冠疫苗全球获取机制（COVAX）与新冠疫苗不平等：二十国集团（G-20）和非洲联盟的案例研究
Public Health Chall. 2024 May 9;3(2):e185. doi: 10.1002/puh2.185. eCollection 2024 Jun.
2
The international politics of disease reporting: Towards post-Westphalianism?疾病报告的国际政治：迈向“后威斯特伐利亚主义”？
Int Polit (Hague). 2012;49(5):591-613. doi: 10.1057/ip.2012.19. Epub 2012 Oct 4.
3
A systemic evaluation of COVID-19 vaccination drives in LICs, LMICs, UMICs, and HICs: Preparedness for future pandemics.对低收入国家、中低收入国家、中高收入国家和高收入国家新冠疫苗接种行动的系统评估：对未来大流行的准备情况
J Family Med Prim Care. 2024 Dec;13(12):5680-5688. doi: 10.4103/jfmpc.jfmpc_594_24. Epub 2024 Dec 9.
4
Challenges in Global Distribution and Equitable Access to Monkeypox Vaccines.全球猴痘疫苗分配与公平获取面临的挑战
Viruses. 2024 Nov 21;16(12):1815. doi: 10.3390/v16121815.
5
Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics.从 COVID-19 中吸取的教训，以降低全球南方的死亡率和发病率：为未来的大流行解决全球疫苗公平问题。
BMJ Glob Health. 2024 Jan 1;9(1):e013680. doi: 10.1136/bmjgh-2023-013680.
6
Health Emergency Risk Management in World Health Organization - South-East Asia Region during 2014-2023: synthesis of experiences.2014 - 2023年世界卫生组织东南亚区域的卫生应急风险管理：经验总结
Lancet Reg Health Southeast Asia. 2023 Oct 29;18:100304. doi: 10.1016/j.lansea.2023.100304. eCollection 2023 Nov.
7
Viewing the global health system as a complex adaptive system - implications for research and practice.将全球卫生系统视为复杂适应系统——对研究和实践的启示。
F1000Res. 2022 Oct 7;11:1147. doi: 10.12688/f1000research.126201.1. eCollection 2022.
8
Canada and the pharmaceutical industry in the time of COVID-19.加拿大和 COVID-19 大流行时期的制药业。
Int J Soc Determinants Health Health Serv. 2023 Oct;53(4):508-517. doi: 10.1177/27551938231195434. Epub 2023 Aug 13.
9
An elephant in the glasshouse? Trade-offs between acceleration and transformation in COVID-19 vaccine innovation policies.温室里的大象？新冠疫苗创新政策中加速与转型之间的权衡
Environ Innov Soc Transit. 2023 Sep;48:100736. doi: 10.1016/j.eist.2023.100736. Epub 2023 May 24.
10
Global pattern and determinants of coronavirus disease 2019 (COVID-19) vaccine coverage and progression: a global ecological study.2019冠状病毒病（COVID-19）疫苗接种覆盖率及进展的全球模式与决定因素：一项全球生态学研究
Glob Health J. 2023 Mar;7(1):18-23. doi: 10.1016/j.glohj.2023.02.003. Epub 2023 Feb 9.
本文引用的文献
1
Pandemic influenza vaccine policy--considering the early evidence.大流行性流感疫苗政策——考量早期证据
N Engl J Med. 2009 Dec 17;361(25):e59. doi: 10.1056/NEJMe0908224. Epub 2009 Sep 10.
2
Poverty, wealth, and access to pandemic influenza vaccines.贫困、财富与大流行性流感疫苗的可及性。
N Engl J Med. 2009 Sep 17;361(12):1129-31. doi: 10.1056/NEJMp0906972. Epub 2009 Aug 12.
3
Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.季节性流感和2009年甲型H1N1流感大流行疫苗的生产能力。
Vaccine. 2009 Aug 20;27(38):5184-6. doi: 10.1016/j.vaccine.2009.06.034. Epub 2009 Jun 27.
4
Influenza virus samples, international law, and global health diplomacy.流感病毒样本、国际法与全球卫生外交。
Emerg Infect Dis. 2008 Jan;14(1):88-94. doi: 10.3201/eid1401.070700.
5
Sharing H5N1 viruses to stop a global influenza pandemic.分享H5N1病毒以阻止全球流感大流行。
PLoS Med. 2007 Nov 20;4(11):e330. doi: 10.1371/journal.pmed.0040330.
Zotero 插件